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Background
Human immunodeficiency virus (HIV) from a family of
retroviruses is a causative organism for acquired
immuno deficiency syndrome (AIDS), affecting more
than 40 million people worldwide [1]. Reverse transcrip-
tion of the HIV single-stranded RNA genome into dou-
ble-stranded DNA is one of the essential key step in the
virus replication life-cycle and acts as lucrative target for
drug action. Till date, out of 20 anti-HIV drugs
approved for the treatment of HIV infection, eleven
approved anti-HIV drugs target RT, and encompass
three classes of agents that inhibit RT by different
mechanisms (Nucleoside Reverse Transcriptase Inhibi-
tors, NRTIs; Non-Nucleoside Reverse Transcriptase
Inhibitors, NNRTIs; Nucleotide Reverse Transcriptase
Inhibitors, NtRTIs) [2]. The NNRTIs serve as an
increasingly important role in the therapy of HIV infec-
tion, due to their unique antiviral potency, high specifi-
city and low toxicity. Present work illustrates the
probable binding affinity, interatomic contacts and
orientation of novel of NNRTIs in development at the
allosteric site of the HIV-RT through an iterative com-
putational process and molecular docking to explicate
the necessary structural requirement for rational drug
design.
Material and methods
Six NNRTIs in development were selected for the study
viz. Etravirine, Rilpivirine, Calanolide A, IDX899,
RDEA806 and Lersivirine). These selected molecules
were rigorously analyzed through Lipinski’s Rule of 5
(Ro5) by molinspiration software [3]. In an order to
explicate the binding affinity, interatomic contacts and
orientation of NNRTIs at the active of HIV-RT, a mole-
cular docking study were carried out by utilizing scoring
function such as PLP1, PLP2, Jain, PMF, Lig_Internal_E-
nergy, binding energy, and ultimately dock score. Dock-
ing study was performed by using the LigandFit as
docking module within package of Discovery Studio 2.5.
Position optimization of both ligand and proteins were
performed by using all-atom CHARMm forcefield with
Adopted Basis set Newton Raphson minimization algo-
rithm until the root mean square (r.m.s) gradient for
potential energy was less than 0.05 kcal/mol/Å. The cav-
ity within a receptor defined as active site and an input
site sphere was defined over the active site with a radius
of 5 Å.
Results
All six molecules successfully passed the Lipinski’s Ro5
filter to be as a probable drug candidate except some
minor violations. In terms of molecular docking, they
presented excellent scoring and binding affinity towards
the receptor due to the close interatomic contacts
through strong H-bonds Lys103 (Calanolide A), His235,
Tyr318 (RDEA806), Lys101 (Rilpivirine, Etravirine)
Val179 (Etravirine), pi-pi Tyr181 (IDX899, RDEA806,
Rilpivirine, Lersivirine) and pi-cation interactions
through Lys101 (RDEA806), Tyr103 (Rilpivirine).
Conclusion
As a concluding remark, preliminary screening by
Lipinski’s Ro5 acted as filter to obtain potential mole-
cule from large datasets, whereas, pi-pi interaction was
coined as a major interatomic interaction for stabilizing
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receptor-ligand complex and minor with hydrogen
bonding and pi-cation interaction. We have anticipated
a pivotal facet for designing the next generation of
NNRTIs with improved activity based upon molecular
docking studies.
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